New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
07:55 EDTCVS, ESRX, CTRXLeerink a buyer of Catamaran ahead of Q2 results
Leerink says it's a buyer of Catamaran (CTRX) ahead of the company's Q2 results as it believes shares have more room to run. The firm is cautious on Express Scripts (ESRX) after hearing from a specialist that service challenges may impact the company's 2015 and 2016 selling seasons. The firm remains positive on CVS Caremark (CVS), but notes shares have outperformed and the company could see retail pressure from recent drug inflation trends.
News For CTRX;ESRX;CVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2015
08:32 EDTCVSCVS Health enters into two new clinical affiliations
CVS Health has entered into new clinical affiliations with two health systems, St. Luke's University Health Network in Bethlehem, Pennsylvania and TriHealth in Cincinnati, Ohio. Through these clinical affiliations, CVS Health will provide prescription and visit information to the participating health care organizations.
August 26, 2015
08:32 EDTCVSCVS Health to partner with telehealth providers to improve patient care
Subscribe for More Information
August 25, 2015
16:01 EDTCVSTarget sees $550M pretax gain after closing CVS transaction
Subscribe for More Information
August 20, 2015
09:20 EDTESRXExpress Scripts rebates to increase due to price protection, says Cleveland
Subscribe for More Information
August 19, 2015
16:00 EDTCVSTarget shares driven higher after earnings, cool after hot open
Subscribe for More Information
11:03 EDTCVSTarget says sees Q3 SSS up 1%-2%
Subscribe for More Information
05:46 EDTESRXStocks with implied volatility movement; ESRX BMY
Subscribe for More Information
August 18, 2015
13:01 EDTCVSEarnings Watch: Target to report Q2 results after management changes
Subscribe for More Information
11:23 EDTESRXExpress Scripts call activity attributed to takeover speculation
Subscribe for More Information
11:10 EDTESRXRumor: Express Scripts strength attributed to takeover speculation
Subscribe for More Information
10:09 EDTCVSCVS Health completes Omnicare acquisition for total enterprise value of $12.9B
Subscribe for More Information
August 17, 2015
13:30 EDTESRXOn The Fly: Top stock stories at midday
Stocks began the session deep in negative territory after a disappointing Empire Manufacturing report. The data got the market off to a weak start as optimism over last week's finish began to fade. The averages continued to drift in a narrow range for the opening hour before reversing and capturing the opening losses. Each of the major equity indices is now back in positive territory sporting slight gains across the board. ECONOMIC EVENTS: In the U.S., the Empire State manufacturing index plunged to -14.92 in August after rebounding to 3.86 in July from June's -1.98. The consensus estimate was 4.75, and the surprising drop puts the index at its lowest point since April 2009. The employment component slid to 1.82, while new orders crashed to -15.70. Meanwhile, the U.S. NAHB homebuilder sentiment index rose to 61 in August from 60 in June and and is the highest since November 2005. The single family sales index edged up to 66 versus a revised 65 last month, while the index of prospective buyer traffic improved to 45 versus 43 previously. In Europe, various Eurozone parliaments prepare to vote on Greece's new EUR86B bailout plan this week. COMPANY NEWS: Liberty Interactive (QVCA) announced this morning an agreement to acquire zulily (ZU) for $18.75 per share in a deal valuing the online shopping site at $2.4B, driving zulily shares up more than 47% in intraday trading. The acquisition will be attributed to Liberty's QVC Group tracking stock, though QVC and zulily will be operated as separate consumer facing brands. On a conference call discussing the acquisition, Liberty Interactive executives noted that the "highly efficient" deal will allow Liberty to reach a younger base. MAJOR MOVERS: Among the notable gainers AVEO Oncology (AVEO), which rose roughly 50% after announcing a license agreement with Novartis (NVS) for the development and commercialization of AVEO's AV-380 drug and related antibodies. Also higher was Kite Pharma (KITE), which advanced roughly 5.4% after clarifying that an earlier patient death in its Phase 1/2 KTE-C19 trial for non-Hodgkin's lymphoma was unrelated to Kite's therapy. Additionally, shares of Target (TGT) have gained roughly 10c despite lingering in negative territory early Monday after the company promoted CFO John Mulligan to the newly created role of EVP and COO and appointed Cathy Smith as EVP and CFO. Prior to joining Target, Smith served as EVP and CFO at St. Louis-based Express Scripts (ESRX). Among the noteworthy losers was KKR (KKR), which lost roughly 2.4% after Samson Resources announced a restructuring agreement late Friday, adding that it expects to file for bankruptcy within 30 days. Also lower was Estee Lauder (EL), which declined nearly 6.5% after its quarterly guidance missed analysts' estimates. INDEXES: Near midday, The Dow was up 65.11, or 0.37%, to 17,542.51, the Nasdaq gained 34.73, or 0.69%, to 5,082.96, and the S&P 500 advanced 8.80, or 0.42%, to 2,101.03.
08:48 EDTESRXTarget names John Mulligan as EVP, COO, Cathy Smith as EVP, CFO
Target Corporation (TGT) promoted John Mulligan to the newly created role of EVP and COO, effective Sept. 1. Mulligan will assume oversight of stores, supply chain and properties. Joining Target as EVP and CFO will be Cathy Smith. Both Mulligan and Smith will report to Target's chairman and chief executive officer, Brian Cornell. Mulligan has worked at the Minneapolis-based company since 1996, when he began as a financial analyst. He has served as the company's CFO since 2012. In 2014, he led the company as the retailer's interim president and CEO from May to August while continuing to act as CFO. Prior to joining Target, Smith served as EVP and CFO at St. Louis-based Express Scripts (ESRX).

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use